Xcelerate is an early-stage Florida-based company operating in two health and wellness businesses. The first, ESN Group (51% owned), markets two plant-based personal care brands: Ceramedx, a therapeutic skincare line targeting dry and sensitive skin conditions like eczema and psoriasis, and Earth Science Naturals, a broader skin, hair, and body care line. Products are manufactured by contract manufacturers in Southern California and sold through natural and conventional grocery distributors like UNFI and KeHE, directly to retailers like Albertsons and Wakefern, and through online channels including Amazon. ESN Group is Xcelerate's only revenue-generating business. The second business, Afiya Sasa Africa (ASA, also 51% owned), licenses AI and augmented reality software from AdviNOW to deliver telemedicine services in Africa, where physician access is limited. Patients use the platform via smartphone to receive AI-assisted triage and connect with licensed physicians. ASA has signed deployment agreements with two hospitals in Tanzania but has not yet generated revenue. ASA plans to generate revenue through subscription fees, hospital technology fees, virtual consultation fees, and potentially national health system contracts, while paying AdviNOW a royalty starting at 3% of gross revenue. Xcelerate has an accumulated deficit of roughly $10M and has been funded almost entirely through interest-free loans from the CEO and principal shareholders. The company's auditors have raised going concern doubts.